MC2171A1 - Production et utilisation de porphyrines - Google Patents

Production et utilisation de porphyrines

Info

Publication number
MC2171A1
MC2171A1 MC89@@D MC2171D MC2171A1 MC 2171 A1 MC2171 A1 MC 2171A1 MC 2171 D MC2171 D MC 2171D MC 2171 A1 MC2171 A1 MC 2171A1
Authority
MC
Monaco
Prior art keywords
porphyrins
production
Prior art date
Application number
MC89@@D
Other languages
English (en)
French (fr)
Inventor
Blaik Hailing
Debra Witkowski
Original Assignee
Fmc Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fmc Corp filed Critical Fmc Corp
Publication of MC2171A1 publication Critical patent/MC2171A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
MC89@@D 1988-12-12 1989-12-08 Production et utilisation de porphyrines MC2171A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US28515188A 1988-12-12 1988-12-12
US33500789A 1989-04-07 1989-04-07
US35133189A 1989-05-03 1989-05-03
PCT/US1989/005599 WO1990006748A2 (en) 1988-12-12 1989-12-08 Use of certain herbicides in cancer treatment and production of protoporphyrin ix

Publications (1)

Publication Number Publication Date
MC2171A1 true MC2171A1 (fr) 1992-05-22

Family

ID=27403508

Family Applications (1)

Application Number Title Priority Date Filing Date
MC89@@D MC2171A1 (fr) 1988-12-12 1989-12-08 Production et utilisation de porphyrines

Country Status (28)

Country Link
EP (1) EP0447491B1 (xx)
JP (1) JP2545000B2 (xx)
KR (1) KR930003116B1 (xx)
AR (1) AR243605A1 (xx)
AT (1) AT400520B (xx)
AU (1) AU633537B2 (xx)
BR (1) BR8907817A (xx)
CA (1) CA2004979A1 (xx)
CH (1) CH681779A5 (xx)
DE (2) DE3991484C2 (xx)
DK (1) DK110791A (xx)
EG (1) EG18822A (xx)
ES (1) ES2051675T3 (xx)
FI (1) FI912784A0 (xx)
GB (1) GB2247404B (xx)
GR (1) GR1000609B (xx)
HU (1) HUT58202A (xx)
IE (1) IE62621B1 (xx)
IL (1) IL92622A (xx)
LU (1) LU87949A1 (xx)
LV (1) LV10303B (xx)
MC (1) MC2171A1 (xx)
NO (1) NO912228D0 (xx)
NZ (1) NZ231658A (xx)
OA (1) OA09362A (xx)
PT (1) PT92546B (xx)
SE (1) SE505938C2 (xx)
WO (1) WO1990006748A2 (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5298502A (en) * 1988-12-12 1994-03-29 Fmc Corporation Method and composition for photodynamic treatment and detection of tumors
US5132101A (en) * 1990-05-04 1992-07-21 Cytopharm, Inc. Acetylene-cumulene porphycene compounds for photodynamic therapy
US5244671A (en) * 1991-01-29 1993-09-14 Cytopharm, Inc. Derivatives of porphycene for photodynamic therapy of cancer
US5179120A (en) * 1991-06-28 1993-01-12 Cytopharm, Inc. Porphycene compounds for photodynamic therapy
TW492975B (en) * 1993-07-26 2002-07-01 Novartis Ag Tryptase inhibitor
GB9318841D0 (en) * 1993-09-10 1993-10-27 Res Foundation Of The Norwegia Composition
US6023012A (en) * 1996-02-28 2000-02-08 Novartis Finance Corporation DNA molecules encoding plant protoporphyrinogen oxidase
US5939602A (en) * 1995-06-06 1999-08-17 Novartis Finance Corporation DNA molecules encoding plant protoporphyrinogen oxidase and inhibitor-resistant mutants thereof
US5767373A (en) 1994-06-16 1998-06-16 Novartis Finance Corporation Manipulation of protoporphyrinogen oxidase enzyme activity in eukaryotic organisms
US6084155A (en) * 1995-06-06 2000-07-04 Novartis Ag Herbicide-tolerant protoporphyrinogen oxidase ("protox") genes
KR19990087356A (ko) * 1996-02-28 1999-12-27 더블류. 하링, 지. 보이롤 식물 프로토포르피리노겐 옥시다제 유전자로부터의 프로모터
JPH10330359A (ja) * 1997-03-31 1998-12-15 Nippon Bayeragrochem Kk フエニルアセチレン誘導体及び除草剤
DE102005017152B4 (de) * 2005-04-13 2007-02-08 Lindauer Dornier Gmbh Verfahren zum Trocknen von vorzugsweise plattenförmigen Produkten und Durchlauftrockner in Mehretagenbauweise
ES2417312T3 (es) 2009-06-19 2013-08-07 Basf Se Benzoxazinonas herbicidas
BR112012009987A2 (pt) * 2009-11-02 2015-09-29 Basf Se ''tetraidroftalimidas de fórmula ia ,processo para preparação de composições herbicidas ativas e método para controlar vegetações indesejadas''
US8669208B2 (en) 2010-10-01 2014-03-11 Basf Se Herbicidal benzoxazinones
CN103260412B (zh) 2010-12-15 2015-09-02 巴斯夫欧洲公司 除草组合物
CN102875569A (zh) * 2012-09-27 2013-01-16 南开大学 具有除草活性和抗肝癌活性的异噁唑并嘧啶酮(或三嗪酮)类化合物
WO2018108695A1 (en) * 2016-12-16 2018-06-21 Basf Se Herbicidal phenyltriazolinones

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4393071A (en) * 1975-03-17 1983-07-12 Naoharu Fujii Method of treating gastric, mammary, lung and uterus tumors
US4404019A (en) * 1980-12-24 1983-09-13 Sumitomo Chemical Company, Limited 3-Chloro-1-phenyl-1,2,4-triazolin-5-ones and their use as herbicides
CH651029A5 (de) * 1980-12-25 1985-08-30 Nihon Nohyaku Co Ltd Triazolin-derivate, verfahren zu ihrer herstellung und sie enthaltende herbizide mittel.
JPS60190711A (ja) * 1984-03-09 1985-09-28 Tokyo Tanabe Co Ltd プロトポルフイリン類注射用製剤
US4755217A (en) * 1987-01-15 1988-07-05 Fmc Corporation Triazinedione herbicides
US4761174A (en) * 1987-04-14 1988-08-02 Fmc Corporation Triazolin-5-one herbicides

Also Published As

Publication number Publication date
JP2545000B2 (ja) 1996-10-16
AU633537B2 (en) 1993-02-04
IL92622A (en) 1996-05-14
LU87949A1 (fr) 1991-12-16
SE9101807D0 (sv) 1991-06-12
WO1990006748A2 (en) 1990-06-28
KR910700046A (ko) 1991-03-13
CA2004979A1 (en) 1990-06-12
FI912784A0 (fi) 1991-06-10
OA09362A (en) 1992-09-15
GB2247404B (en) 1993-03-03
IE893925L (en) 1990-06-12
AU4822290A (en) 1990-07-10
JPH04501420A (ja) 1992-03-12
EP0447491A1 (en) 1991-09-25
DK110791A (da) 1991-08-12
GR890100817A (en) 1991-03-15
PT92546A (pt) 1990-06-29
WO1990006748A3 (en) 1990-10-04
CH681779A5 (xx) 1993-05-28
SE505938C2 (sv) 1997-10-27
EG18822A (en) 1994-09-29
EP0447491B1 (en) 1993-08-11
BR8907817A (pt) 1991-10-22
ES2051675T1 (es) 1994-07-01
DE3991484T (xx) 1991-11-21
DK110791D0 (da) 1991-06-11
PT92546B (pt) 1995-09-12
LV10303A (lv) 1994-10-20
NO912228L (no) 1991-06-11
NZ231658A (en) 1992-05-26
KR930003116B1 (ko) 1993-04-19
HUT58202A (en) 1992-02-28
GB9110472D0 (en) 1991-11-27
IE62621B1 (en) 1995-02-22
SE9101807L (sv) 1991-06-12
GR1000609B (el) 1992-08-31
AT400520B (de) 1996-01-25
LV10303B (en) 1995-08-20
AR243605A1 (es) 1993-08-31
ATA903489A (de) 1995-06-15
ES2051675T3 (es) 1994-11-01
DE3991484C2 (de) 1995-02-23
GB2247404A (en) 1992-03-04
NO912228D0 (no) 1991-06-11
IL92622A0 (en) 1990-08-31

Similar Documents

Publication Publication Date Title
MC2171A1 (fr) Production et utilisation de porphyrines
BR8703207A (pt) Aplicador de tampao catamenial;conjunto de aplicador e de tampao catamenial;tampao catamenial
DE68926347T2 (de) Speicherstruktur und verwendung
ES2017015B3 (es) Procedimiento de preparacion de disulfuros y polisulfuros organicos
DK254488D0 (da) Azaindol- og indolizinderivater
BR8807050A (pt) Aplicador de tampao e tampao sanitario
DE220574T1 (de) Menschliches interferon-beta2a und interferon-beta2b
DK641587D0 (da) Benzofuran- og benzopyranderivater
DK617487A (da) Pyrrolderivater og deoxyanaloge deraf
PT8867T (pt) Tabuleiro empilhavel com varias seccoes de apoio e encaixe
DK139286D0 (da) Inden- og naphthalenderivater
BR8604976A (pt) Brinquedo de figura
DE3854981T2 (de) 1-Pyrrolidinacetamid-Derivate und ihre Verwendung
KR880013928A (ko) 신규 5-테트라히드로푸란 및 테트라 히드로티오펜
PT89072A (pt) Estojo estanque e impermeavel
KR900009427A (ko) 산소 발생제
FR2635755B1 (fr) Capsule de securite et de garantie
FR2588259B1 (fr) Bis-acridiniques monopontes et bis-acridiniques bipontes
IT8847653A0 (it) Sizzante comprendente 5 - idroscomposizione farmaceutica anoressitrpofano
TR24296A (tr) Ferrokrom ueretimine mahsus usul ve tertibat
FR2636309B1 (fr) Capsule de securite et de garantie
ZA899447B (en) Production and use of porphyrins
BR8903829A (pt) Purificacao de telomeros preparados de cloro-tri-fluor-etileno e tri-cloro-tri-fluor-etano
KR900004740U (ko) 일부인
KR890018840U (ko) 쑥뜸기